Stay updated on Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the terminated UPGRADE-A study record, including its eligibility criteria, treatment plan, outcomes, and record dates, instead of a 403 Forbidden screen.
    Difference
    48%
    Check dated 2026-11-08T00:21:51.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T18:13:52.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T19:21:12.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T21:50:26.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1; the page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T21:52:32.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record, indicating restricted access or a server-side issue preventing viewing the trial details. This change affects the user experience by preventing access to the main content on the page.
    Difference
    0.5%
    Check dated 2026-09-26T21:38:23.000Z thumbnail image

Stay in the know with updates to Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.